Quetiapine Fumarate Sustained Release : Unveiling QT-PINE SR 100

Quetiapine Fumarate Sustained Release & QT-PINE SR 100 

Quetiapine Fumarate Sustained Release stands out as a valuable therapeutic option. Offering sustained-release formulation, QT-PINE SR 100 provides a steady delivery of medication, ensuring consistent efficacy and improved patient adherence. This comprehensive guide explores the uses, dosage guidelines, benefits, potential side effects, and other essential considerations associated with QT-PINE SR 100.

Understanding QT-PINE SR 100:

1. Extended Release Formulation:

QT-PINE SR 100 features an extended-release formulation of Quetiapine Fumarate. This formulation allows for gradual and sustained release of the medication over an extended period, typically 24 hours. As a result, patients require fewer daily doses compared to immediate-release formulations, leading to enhanced convenience and improved compliance.

2. Therapeutic Uses:

QT-PINE SR 100 is primarily prescribed for the treatment of schizophrenia and bipolar disorder. It is also indicated for the management of depressive episodes in bipolar disorder and adjunctive treatment of major depressive disorder. Quetiapine, the active ingredient in QT-PINE SR 100, acts as an antagonist at multiple neurotransmitter receptors, including dopamine and serotonin receptors, to alleviate symptoms of psychosis and mood disorders.

3. Dosage Guidelines:

The recommended starting dose of QT-PINE SR 100 for schizophrenia is typically 50mg once daily, with gradual titration as tolerated to a target dose of 300-400mg daily. For bipolar disorder, the initial dose may range from 50mg to 100mg once daily, with adjustments made based on individual response. 

4. Benefits of Sustained Release:

QT-PINE SR 100 offers several advantages over immediate-release formulations. The sustained release profile ensures steady blood levels of Quetiapine throughout the day, minimizing fluctuations and providing consistent symptom control. This can result in improved tolerability and reduced risk of certain side effects associated with rapid changes in drug concentration.

5. Potential Side Effects:

Common side effects of QT-PINE SR 100 may include drowsiness, dizziness, dry mouth, and weight gain. Some patients may experience metabolic changes, such as elevated cholesterol or triglyceride levels. Rare but serious side effects include orthostatic hypotension, tardive dyskinesia, and neuroleptic malignant syndrome.

Conclusion:

In conclusion, QT-PINE SR 100 offers a convenient and effective treatment option for individuals with schizophrenia and bipolar disorder. Its sustained-release formulation provides consistent symptom control and improved patient adherence compared to immediate-release formulations. However, like all medications, QT-PINE SR 100 carries potential risks and side effects that should be carefully considered and monitored. Patients should work closely with their healthcare provider to determine if QT-PINE SR 100 is the right treatment option for their psychiatric condition. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW